39 filings
8-K
RPTX
Repare Therapeutics Inc
7 May 24
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
4:10pm
8-K
RPTX
Repare Therapeutics Inc
26 Apr 24
Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
4:14pm
8-K
RPTX
Repare Therapeutics Inc
28 Feb 24
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:10am
8-K
RPTX
Repare Therapeutics Inc
12 Feb 24
Termination of a Material Definitive Agreement
4:48pm
8-K
RPTX
Repare Therapeutics Inc
25 Jan 24
Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment
2:29pm
8-K
1cccio7x
12 Jan 24
Repare Therapeutics Provides Corporate Update and Highlights Anticipated Key 2024 Milestones
4:05pm
8-K
6h67 pc1cx1w
15 Nov 23
Regulation FD Disclosure
7:20am
8-K
oxfye9o
9 Nov 23
Repare Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
7:05am
8-K
yd4ykbk 784uiikln
13 Oct 23
Regulation FD Disclosure
5:15pm
8-K
kgzbslntuvfm49p4a9
13 Oct 23
Repare Therapeutics Announces Positive Initial Data from Phase 1 MYTHIC Clinical Trial
9:47am
8-K
lme17eztao6
6 Oct 23
Regulation FD Disclosure
7:56am
8-K
bc7wr26
9 Aug 23
Repare Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
4:09pm
8-K
6tia nx8wg2
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
icl jh2a8ovf61e
7 Jun 23
Other Events
4:31pm
8-K
486oib92
9 May 23
Repare Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
7hlzbwq 2u
28 Apr 23
Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its Board of Directors
4:27pm
8-K
eeft32 idh2kj2
18 Apr 23
Repare Therapeutics Presents Initial Clinical Data from the Phase 1/2 TRESR and ATTACC
10:24am
8-K
mqt2ae0dn84uhvysm
10 Mar 23
Other Events
4:57pm
8-K
idoogcum rsd5tqir6ru
28 Feb 23
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:07pm
8-K
07sie33uncr 47foe
9 Nov 22
Repare Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:05pm